DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Exhibition & Sponsorship Opportunities
    • Attending Exhibitors and Sponsors
    • The DDL Incubator
    • New Researcher Network
    • Hotel and Travel
    • Call for Papers
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • RDD 2027
  • The Aerosol Society logo
Mark Nagel

Mark Nagel

Head of Aerosol Science at Trudell Medical International, Canada

Paper: Use of A Sectional Adult Nasal Airway Model for the Evaluation of Nasal Delivery Devices and Administration Techniques

Download Paper

Mark is currently the Head of Aerosol Science at Trudell Medical International, a Canadian medical device company specializing in Respiratory Drug Delivery and Airway Clearance. He has more than 25 years’ experience in the design, development, and testing of aerosol drug delivery devices. He has contributed to several regulatory submissions and over 130 publications, many of which have been published in the peer reviewed literature, conference presentations, and conference papers, combined with several patents and applications currently under review. He is a co-chair of the New Device and Emerging Therapies E-Health networking group within the International Society for Aerosols in Medicine (ISAM).

Video of Mark Nagel

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk